Bloodstream infections (BSI) in COVID-19 patients admitted to a tertiary care hospital: A retrospective study

S. Bhat K, Vidya Jayasekaran, Catherine Veronica Sailas, N. Vasanthi, Shashikala Nair
{"title":"Bloodstream infections (BSI) in COVID-19 patients admitted to a tertiary care hospital: A retrospective study","authors":"S. Bhat K, Vidya Jayasekaran, Catherine Veronica Sailas, N. Vasanthi, Shashikala Nair","doi":"10.18231/j.ijmr.2023.016","DOIUrl":null,"url":null,"abstract":"Bloodstream infections (BSIs) may cause significant adverse clinical outcomes among patients affected by Coronavirus disease 2019 (COVID-19). This study was conducted with the objective to characterize the bacterial isolates and their susceptibility pattern and to document the patient outcome as well as skin disinfection measures followed during the venepuncture for the blood collection procedure.All blood cultures received from COVID-19 patients admitted in various COVID care wards and ICUs for a period of two years from June 2020 to May 2022 were included in the study. An automated BacT/ALERT system was used for blood culture. The microbial identification and antimicrobial susceptibility testing were done by standard methods. Patient demographic and treatment details and infection control and prevention practices followed during the blood specimen collection were documented.Out of 172 COVID-19-positive patients blood samples were sent for blood culture with clinical suspicion of sepsis. Out of these, 4.2% were positive. The median age of COVID-19 patients with positive blood cultures was 55 years and about 67% of patients had associated comorbidities. About 31% of patients were admitted to ICUs for their management. The blood culture positivity was documented more among patients with ICU admission, underlying comorbidities, and the presence of an indwelling device. Gram-positive bacterial isolation was more than gram-negative bacteria. About 54% showed clinical improvement at the time of discharge and death was recorded in 19% of patients. There was a lack of strict adherence to the aseptic techniques during the venepuncture for blood collection.The incidence of bloodstream infections documented was low for COVID-19 patients. Hence, empirical antimicrobial agents should be used with care and prompt discontinuation should be done on clinical improvement and based on the microbiology culture report.","PeriodicalId":13428,"journal":{"name":"Indian Journal of Microbiology Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Microbiology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.ijmr.2023.016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Bloodstream infections (BSIs) may cause significant adverse clinical outcomes among patients affected by Coronavirus disease 2019 (COVID-19). This study was conducted with the objective to characterize the bacterial isolates and their susceptibility pattern and to document the patient outcome as well as skin disinfection measures followed during the venepuncture for the blood collection procedure.All blood cultures received from COVID-19 patients admitted in various COVID care wards and ICUs for a period of two years from June 2020 to May 2022 were included in the study. An automated BacT/ALERT system was used for blood culture. The microbial identification and antimicrobial susceptibility testing were done by standard methods. Patient demographic and treatment details and infection control and prevention practices followed during the blood specimen collection were documented.Out of 172 COVID-19-positive patients blood samples were sent for blood culture with clinical suspicion of sepsis. Out of these, 4.2% were positive. The median age of COVID-19 patients with positive blood cultures was 55 years and about 67% of patients had associated comorbidities. About 31% of patients were admitted to ICUs for their management. The blood culture positivity was documented more among patients with ICU admission, underlying comorbidities, and the presence of an indwelling device. Gram-positive bacterial isolation was more than gram-negative bacteria. About 54% showed clinical improvement at the time of discharge and death was recorded in 19% of patients. There was a lack of strict adherence to the aseptic techniques during the venepuncture for blood collection.The incidence of bloodstream infections documented was low for COVID-19 patients. Hence, empirical antimicrobial agents should be used with care and prompt discontinuation should be done on clinical improvement and based on the microbiology culture report.
三级医院收治的COVID-19患者血液感染(BSI):一项回顾性研究
2019冠状病毒病(COVID-19)患者的血液感染(bsi)可能会导致显著的不良临床结果。本研究的目的是表征细菌分离物及其敏感性模式,并记录患者结果以及在静脉穿刺采血过程中采取的皮肤消毒措施。从2020年6月至2022年5月的两年间,在各个COVID护理病房和icu住院的COVID-19患者接受的所有血液培养均被纳入研究。采用自动BacT/ALERT系统进行血培养。采用标准方法进行微生物鉴定和药敏试验。记录了患者人口统计和治疗细节以及在采集血样期间遵循的感染控制和预防措施。对172例新冠肺炎阳性患者进行了临床怀疑为败血症的血液培养。其中,4.2%为阳性。血液培养阳性的COVID-19患者的中位年龄为55岁,约67%的患者有相关的合并症。约31%的患者因其管理而入住icu。在ICU住院、潜在合并症和留置装置的患者中,血培养阳性的记录更多。革兰氏阳性菌多于革兰氏阴性菌。约54%的患者在出院时表现出临床改善,19%的患者死亡。在静脉穿刺采血过程中,缺乏严格遵守无菌技术。记录在案的COVID-19患者血液感染发生率较低。因此,应谨慎使用经验性抗菌药物,并应根据临床改善和微生物培养报告及时停药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信